CD55

CD55 분자 정보

영어 이름Complement decay-accelerating factor시판 약물 수0
임상 약물 수3표적 별명DAF,Complement decay-accelerating factor,CD55,CD55 Molecule (Cromer Blood Group),CD55 Molecule, Decay Accelerating Factor For Complement (Cromer Blood Group),CD55 Antigen,CR,Decay Accelerating Factor For Complement (CD55, Cromer Blood Group System),Cromer Blood Group Antigen,CHAPLE,CROM,TC,CD55 Antigens
최고 연구 개발 단계Phase 2 Clinical
영어 이름Complement decay-accelerating factor
표적 별명DAF,Complement decay-accelerating factor,CD55,CD55 Molecule (Cromer Blood Group),CD55 Molecule, Decay Accelerating Factor For Complement (Cromer Blood Group),CD55 Antigen,CR,Decay Accelerating Factor For Complement (CD55, Cromer Blood Group System),Cromer Blood Group Antigen,CHAPLE,CROM,TC,CD55 Antigens
시판 약물 수0
임상 약물 수3
최고 연구 개발 단계Phase 2 Clinical

CD55 제품 목록

  • 속성

    Protein (2)

  • 제품 라이브러리

    온라인 (2)

  • Human (2)

  • 태그

    His Tag (1)His Tag & Avi Tag (1)

  • 마커

    Unconjugated (1)Biotin-labeled (1)

제품 번호발현 시스템제품 설명단백질 구조순도특성
CD5-H5225
Human
HEK293
Human CD55 / DAF Protein, His Tag, low endotoxin
CD5-H82E4
Human
HEK293
Biotinylated Human CD55 / DAF Protein, His,Avitag™ (MALS verified)
총 수량2
  • 1

CD55분자 배경

CD55 is also known as DAF or decay­accelerating factor, is a member of the RCA (regulators of complement activation) family characterized by four to 30 SCRs (short consensus repeats) in their plasma-exposed regions. CD55 /DAF is a 70 kDa membrane protein that regulates the complement system on the cell surface. It prevents the assembly of the C3bBb complex (the C3-convertase of the alternative pathway) or accelerates the disassembly of preformed convertase, thus blocking the formation of the membrane attack complex. This glycoprotein is broadly distributed among hematopoietic and non-hematopoietic cells. It is a determinant for the Cromer blood group system. CD55 is known to bind CD97 via the first SCR. It also binds physiologically­generated C3 convertases with its second and third SCRs. Binding results in an accelerated “decay”, or dissociation of active C3 convertases, thus blocking the development of C’ attack complexes on nonforeign cells. Finally, viruses and bacteria are also known to utilize multiple SCR sites for infection.

CD55분자 별명

CD55,DAF,CR,CROM,TC

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
GebasaxturevV-937; CVA-21Phase 2 ClinicalViralytics LtdBreast Neoplasms; Head and Neck Neoplasms; Melanoma; Neoplasm Metastasis; Prostatic Neoplasms; Urinary Bladder Neoplasms
상세
PAT-SC1SC-1; PAT-SC1; PAT-SC-1Phase 2 ClinicalOncomab GmbhStomach Neoplasms
상세
Recombinant coxsackievirus B3Phase 1 ClinicalWuhan Boweid Biotechnology Co LtdNeoplasms
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호